Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Emily J. Colbeck"'
Autor:
Awen Gallimore, Ann Ager, Carl F. Ware, Andrew Godkin, Lee Parry, Anwen Williams, Scott Cutting, Molly Browne, Ralph Schulz, Kathryn Smart, James P. Hindley, Emma Jones, Emily J. Colbeck
T-cell infiltration into tumors represents a critical bottleneck for immune-mediated control of cancer. We previously showed that this bottleneck can be overcome by depleting immunosuppressive Foxp3+ regulatory T cells (Tregs), a process that can inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d820ee45b5ce6a9a231ca33a3475a86
https://doi.org/10.1158/2326-6066.c.6547951.v1
https://doi.org/10.1158/2326-6066.c.6547951.v1
Autor:
Awen Gallimore, Ann Ager, Carl F. Ware, Andrew Godkin, Lee Parry, Anwen Williams, Scott Cutting, Molly Browne, Ralph Schulz, Kathryn Smart, James P. Hindley, Emma Jones, Emily J. Colbeck
S1. Tumor HEV identified by PNAd staining are also positive for MAdCAM-1. S2. Efficacy of monoclonal antibody treatments to deplete immune cell subsets. S3. Splenic Marginal Zone B cells are profoundly decreased after treatment with LTbetaR.Fc. S4. S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2126e4eabe034ca6c975b3444c54b3f
https://doi.org/10.1158/2326-6066.22535824.v1
https://doi.org/10.1158/2326-6066.22535824.v1
Autor:
Awen Gallimore, Ann Ager, Carl F. Ware, Andrew Godkin, Lee Parry, Anwen Williams, Scott Cutting, Molly Browne, Ralph Schulz, Kathryn Smart, James P. Hindley, Emma Jones, Emily J. Colbeck
Table S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::218f3814581ec10d9d40da756d23cb77
https://doi.org/10.1158/2326-6066.22535821
https://doi.org/10.1158/2326-6066.22535821
Autor:
Leanne Peiser, Jessica Davies, Divya Pattabiraman, Ruth Chu, Simon P. Fletcher, Oliver E. Amin, Emily J. Colbeck, Laura J. Pallett, William Rosenberg, Hassan Javanbakht, Sophie Lehar, Mala K. Maini, Christian R. Frey, Shahzada Khan, Holly Micolochick Steuer, Dhivya Ramakrishnan, Stephane Daffis, Adam Palazzo
Publikováno v:
Hepatology (Baltimore, Md.)
Background and aims GS-9688 (selgantolimod) is a toll-like receptor 8 agonist in clinical development for the treatment of chronic hepatitis B (CHB). Antiviral activity of GS-9688 has previously been evaluated in vitro in HBV-infected hepatocytes and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06186dd4f42c9e4f3b2e604b979501fa
https://doi.org/10.1002/hep.31695
https://doi.org/10.1002/hep.31695
Autor:
James P. Hindley, Ralph Schulz, Lee Parry, Emily J. Colbeck, Emma Jones, Scott Cutting, Awen Gallimore, Andrew James Godkin, Anwen Sian Williams, Ann Ager, Kathryn Smart, Carl F. Ware, Molly Browne
Publikováno v:
Cancer Immunology Research. 5:1005-1015
T-cell infiltration into tumors represents a critical bottleneck for immune-mediated control of cancer. We previously showed that this bottleneck can be overcome by depleting immunosuppressive Foxp3+ regulatory T cells (Tregs), a process that can inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de6c02e216e5fbee1fe2f9ebc5cb78f1
https://doi.org/10.1158/2326-6066.cir-17-0131
https://doi.org/10.1158/2326-6066.cir-17-0131
Autor:
Stephane Daffis, Colette Sitali, William Rosenberg, Divya Pattabiraman, Oliver E. Amin, Laura J. Pallett, Mala K. Maini, Simon P. Fletcher, Emily J. Colbeck
Publikováno v:
Journal of Hepatology. 70:e445
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bc9ada10385450bbdc8ca3192f58150
https://doi.org/10.1016/s0618-8278(19)30877-1
https://doi.org/10.1016/s0618-8278(19)30877-1
Autor:
Emily J, Colbeck, James P, Hindley, Kathryn, Smart, Emma, Jones, Anja, Bloom, Hayley, Bridgeman, Rhoanne C, McPherson, Darryl G, Turner, Kristin, Ladell, David A, Price, Richard A, O'Connor, Stephen M, Anderton, Andrew J, Godkin, Awen M, Gallimore
Publikováno v:
Oncotarget
Foxp3(+) regulatory T cells (Tregs) are often highly enriched within the tumor-infiltrating T cell pool. Using a well-characterised model of carcinogen-induced fibrosarcomas we show that the enriched tumor-infiltrating Treg population comprises large
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3ea72491059ba2df9a95238f2222bba6
https://pubmed.ncbi.nlm.nih.gov/26433463
https://pubmed.ncbi.nlm.nih.gov/26433463
Autor:
James P. Hindley, Beatrice Ondondo, Emily J. Colbeck, Bernhard Moser, Emma Jones, Kathryn Smart, Sarah Nicol Lauder, Andrew James Godkin, Awen Gallimore, Ann Ager
Publikováno v:
Immunology
The frequency of CD4+ Foxp3+ regulatory T (Treg) cells is often significantly\ud increased in the blood of tumour-bearing mice and people with\ud cancer. Moreover, Treg cell frequencies are often higher in tumours compared\ud with blood and lymphoid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72568006436d9e7b297d2a3aaadbc855
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 10, Iss 3, p e1003968 (2014)
PLoS Pathogens, Vol 10, Iss 3, p e1003968 (2014)
Fv1 is the prototypic restriction factor that protects against infection by the murine leukemia virus (MLV). It was first identified in cells that were derived from laboratory mice and was found to be homologous to the gag gene of an endogenous retro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f5b25d4f1e2825a236d0ac11e799e86
https://doi.org/10.1371/journal.ppat.1003968
https://doi.org/10.1371/journal.ppat.1003968